Reuters logo
BRIEF-Pascal Biosciences acquires technology to treat leukemia from the University of New Mexico
September 11, 2017 / 1:15 PM / 8 days ago

BRIEF-Pascal Biosciences acquires technology to treat leukemia from the University of New Mexico

Sept 11 (Reuters) - Pascal Biosciences Inc

* Pascal Biosciences Inc - has executed an exclusive, worldwide license option agreement with STC

* Pascal Biosciences - ‍executed license option deal with STC to acquire therapeutic monoclonal antibody for B-cell precursor acute lymphoblastic leukemia​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below